Metabolismo f Nine Synthetic Cannabinoid Receptor Agontsts Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS

被引:9
作者
Hutter, Melanie [1 ]
Broecker, Sebastian [2 ]
Kneisel, Stefan [1 ]
Franz, Florian [1 ,3 ]
Brandt, Simon D. [4 ]
Auwaerter, Volker [1 ]
机构
[1] Univ Freiburg, Med Ctr, Inst Forens Med, Fac Med,Forens Toxicol, Albertstr 9, D-79104 Freiburg, Germany
[2] Broeckers Solut, Dyrotzer Str 8, D-13583 Berlin, Germany
[3] Univ Freiburg, Hermann Staudinger Grad Sch, Hebelstr 27, D-79104 Freiburg, Germany
[4] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 3AF, Merseyside, England
关键词
Synthetic cannabinoid receptor agonists; metabolism; LC-MS/MS; aminoalkylindoles; clinical toxicology; forensic toxicology; TANDEM MASS-SPECTROMETRY; DESIGNER DRUGS; QUANTITATIVE MEASUREMENT; HUMAN HEPATOCYTES; HUMAN SERUM; GC-MS; IDENTIFICATION; QUANTIFICATION; BLOOD; VALIDATION;
D O I
10.2174/1389201019666180509163114
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: 'Herbal mixtures' containing synthetic cannabinoid receptor agonists (SCRAs) are promoted as legal alternative to marihuana and are easily available via the Internet. Keeping analytical methods for the detection of these SCRAs up-to-date is a continuous challenge for clinicians and toxicologists due to the high diversity of the chemical structures and the frequent emergence of new compounds. Since many SCRAs are extensively metabolized, analytical methods used for urine testing require previous identification of the major metabolites of each compound. Objective: The aim of this study was to identify the in vivo major metabolites of nine SCRAs (AM 694, AM -2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144, XLR-11) for unambiguous detection of a drug uptake by analysis of urine samples. Method: Positive urine samples from patients of hospitals, detoxification and therapy centers as well as forensic-psychiatric clinics were analyzed by means of liquid chromatography-tandem mass spectrometry (LC-MS/MS) and liquid chromatography-quadrupole time-of-flight mass spectrometry (LCqToF-MS) for investigation of the major in vivo metabolites. Results: For all investigated SCRAs, monohydroxylation, dihydroxylation and/or formation of the N-hexanoic/pentanoic acid metabolites were among the most abundant metabolites detected in human urine samples. Substitution of the fluorine atom was observed to be an important metabolic reaction for compounds carrying an N-(5-fluoropentyl) side chain. N-Dealkylated metabolites were not detected in vivo. Conclusion: The investigated metabolites facilitate the reliable detection of drug uptake by analysis of urine samples. For distinction between uptake of the fluorinated and the non-fluorinated analogs, the N-(4-hydroxypentyl) metabolite of the non-fluorinated analog was identified as a useful analytical target and consumption marker.
引用
收藏
页码:144 / 162
页数:19
相关论文
共 64 条
[1]   Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine [J].
Adamowicz, Piotr ;
Zuba, Dariusz ;
Sekula, Karolina .
FORENSIC SCIENCE INTERNATIONAL, 2013, 233 (1-3) :320-327
[2]   Detection and Quantification of New Designer Drugs in Human Blood: Part 1 Synthetic Cannabinoids [J].
Ammann, Julia ;
McLaren, Jenna M. ;
Gerostamoulos, Dimitri ;
Beyer, Jochen .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2012, 36 (06) :372-380
[3]  
[Anonymous], 2011, SYNTH CANN HERB PROD
[4]   In vivo detection of the new psychoactive substance AM-694 and its metabolites [J].
Bertol, Elisabetta ;
Vaiano, Fabio ;
Di Milia, Maria Grazia ;
Mari, Francesco .
FORENSIC SCIENCE INTERNATIONAL, 2015, 256 :21-27
[5]   Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing [J].
Beuck, Simon ;
Moeller, Ines ;
Thomas, Andreas ;
Klose, Annika ;
Schloerer, Nils ;
Schaenzer, Wilhelm ;
Thevis, Mario .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2011, 401 (02) :493-505
[6]   Analytical Data for Identification of the Cannabimimetic Phenylacetylindole JWH-203 [J].
Bononi, Monica ;
Belgi, Paolo ;
Tateo, Fernando .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2011, 35 (06) :360-363
[7]   Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter System [J].
Cannaert, Annelies ;
Franz, Florian ;
Auwaerter, Volker ;
Stove, Christophe P. .
ANALYTICAL CHEMISTRY, 2017, 89 (17) :9527-9536
[8]   Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices [J].
Castaneto, Marisol S. ;
Wohlfarth, Ariane ;
Desrosiers, Nathalie A. ;
Hartman, Rebecca L. ;
Gorelick, David A. ;
Huestis, Marilyn A. .
DRUG METABOLISM REVIEWS, 2015, 47 (02) :124-174
[9]   Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands [J].
Chimalakonda, Krishna C. ;
Seely, Kathryn A. ;
Bratton, Stacie M. ;
Brents, Lisa K. ;
Moran, Cindy L. ;
Endres, Gregory W. ;
James, Laura P. ;
Hollenberg, Paul F. ;
Prather, Paul L. ;
Radominska-Pandya, Anna ;
Moran, Jeffery H. .
DRUG METABOLISM AND DISPOSITION, 2012, 40 (11) :2174-2184
[10]   Conjugation of Synthetic Cannabinoids JWH-018 and JWH-073, Metabolites by Human UDP-Glucuronosyltransferases [J].
Chimalakonda, Krishna C. ;
Bratton, Stacie M. ;
Le, Vi-Huyen ;
Yiew, Kan Hui ;
Dineva, Anna ;
Moran, Cindy L. ;
James, Laura P. ;
Moran, Jeffery H. ;
Radominska-Pandya, Anna .
DRUG METABOLISM AND DISPOSITION, 2011, 39 (10) :1967-1976